Articlenpj antimicrobials and resistance2026
Enhancing quality of antimicrobial prescribing through 'Ask Eolas' (language model): a user-testing and simulation evaluation.
Article in npj antimicrobials and resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We aimed to assess prescribing accuracy, error reduction, usability, and clinician confidence of Ask Eolas (a retrieval-augmented generation-enhanced AI-CDSS) compared to existing antimicrobial guidance tools. We conducted a structured simulation single-site study evaluating Ask Eolas across 45 prescribing cases with healthcare professionals to assess prescribing accuracy. Among 45 participants, Ask Eolas achieved zero prescribing errors versus six and eight documented errors in the two comparator groups (Eolas App and PDF Guidelines), respectively (p < 0.001). The number needed to treat was 1.9 for Ask Eolas versus traditional guidelines, indicating one additional error-free prescription for every two clinicians switching to Ask Eolas. Ask Eolas significantly improved prescribing accuracy while enhancing usability, clinician confidence, and system transparency compared to existing tools. These findings align with TRUST-AI framework principles for safe AI-CDSS deployment, supporting further investigation through real-world implementation studies incorporating live data integration, confidence calibration systems, and comprehensive auditability features in antimicrobial stewardship programmes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.